1. Gastroprotectant Rebamipide: review of action mechanisms and clinical applications
   null null et al, 2022, Glavvrač (Chief Medical Officer) CrossRef
2. A review of the mechanism and prophylaxis of acetyl salicylic acid-induced injury of the small intestine
   Osamu Handa et al, 2018, Free Radical Research CrossRef
3. Biopharmaceutical characterization of rebamipide: The role of mucus binding in regional-dependent intestinal permeability
   Milica Markovic et al, 2020, European Journal of Pharmaceutical Sciences CrossRef
4. Urolithin A-mediated augmentation of intestinal barrier function through elevated secretory mucin synthesis
   Takeshi Yasuda et al, 2024, Scientific Reports CrossRef
5. Erosive and ulcerative lesions of the digestive tract: optimization of diagnosis and management tactics
   Mikhail A. Osadchuk et al, 2022, Terapevticheskii arkhiv CrossRef
6. Mucus reduction promotes acetyl salicylic acid-induced small intestinal mucosal injury in rats
   Yosuke Suyama et al, 2018, Biochemical and Biophysical Research Communications CrossRef
7. Using human iPS cell-derived enterocytes as novel in vitro model for the evaluation of human intestinal mucosal damage
   Satoshi Kondo et al, 2018, Inflammation Research CrossRef
8. Pic Protein From Enteroaggregative E. coli Induces Different Mechanisms for Its Dual Activity as a Mucus Secretagogue and a Mucinase
   Fernando Flores-Sanchez et al, 2020, Frontiers in Immunology CrossRef
9. High-Fat Diet Causes Constipation in Mice via Decreasing Colonic Mucus
   Rieko Mukai et al, 2020, Digestive Diseases and Sciences CrossRef
10. The phenomenon of intestinal permeability and its association with cardiovascular disease. Current status
    D. A. Kashtanova et al, 2020, Cardiovascular Therapy and Prevention CrossRef
11. Pharmacological mechanisms of chitotriose as a redox regulator in the treatment of rat inflammatory bowel disease
    Kai Hu et al, 2022, Biomedicine & Pharmacotherapy CrossRef
12. The value of increased intestinal permeability in the pathogenesis of internal diseases
    Asfold I. Parfenov, 2024, Terapevticheskii arkhiv CrossRef
13. The AT1 Receptor Blocker Telmisartan Reduces Intestinal Mucus Thickness in Obese Mice
    Laura Nickel et al, 2022, Frontiers in Pharmacology CrossRef
14. Gastrointestinal Disasters of Cetuximab in the Treatment of Metastatic Colorectal Cancer: Mechanism and its Effect on Prognosis
    null null et al, 2020, Aging Pathobiology and Therapeutics CrossRef
15. Nanosecond pulsed electric fields impair viability and mucin expression in mucinous colorectal carcinoma cell
    Yiran Gu et al, 2021, Bioelectrochemistry CrossRef